214 related articles for article (PubMed ID: 8808781)
21. Clonazepam microencapsulation in poly-D,L-lactide-co-glycolide microspheres.
Benelli P; Conti B; Genta I; Costantini M; Montanari L
J Microencapsul; 1998; 15(4):431-43. PubMed ID: 9651865
[TBL] [Abstract][Full Text] [Related]
22. Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes.
De Rosa G; Quaglia F; La Rotonda MI; Appel M; Alphandary H; Fattal E
J Pharm Sci; 2002 Mar; 91(3):790-9. PubMed ID: 11920765
[TBL] [Abstract][Full Text] [Related]
23. Clonazepam release from poly(DL-lactide-co-glycolide) nanoparticles prepared by dialysis method.
Nah JW; Paek YW; Jeong YI; Kim DW; Cho CS; Kim SH; Kim MY
Arch Pharm Res; 1998 Aug; 21(4):418-22. PubMed ID: 9875469
[TBL] [Abstract][Full Text] [Related]
24. Biodegradable bromocryptine mesylate microspheres prepared by a solvent evaporation technique. I: Evaluation of formulation variables on microspheres characteristics for brain delivery.
Arica B; Kaş HS; Orman MN; Hincal AA
J Microencapsul; 2002; 19(4):473-84. PubMed ID: 12396384
[TBL] [Abstract][Full Text] [Related]
25. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties.
Jalil R; Nixon JR
J Microencapsul; 1990; 7(3):297-325. PubMed ID: 2200861
[TBL] [Abstract][Full Text] [Related]
26. Submicronparticles from biodegradable polymers.
Jobmann M; Rafler G
Int J Pharm; 2002 Aug; 242(1-2):213-7. PubMed ID: 12176249
[TBL] [Abstract][Full Text] [Related]
27. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
Kumar PS; Ramakrishna S; Saini TR; Diwan PV
Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
[TBL] [Abstract][Full Text] [Related]
28. In vitro controlled release kinetics of local anaesthetics from poly(D,L-lactide) and poly(lactide-co-glycolide) microspheres.
Le Corre P; Rytting JH; Gajan V; Chevanne F; Le Verge R
J Microencapsul; 1997; 14(2):243-55. PubMed ID: 9132474
[TBL] [Abstract][Full Text] [Related]
29. Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 2. Parameters determining microsphere formation.
Thomasin C; Merkle HP; Gander B
J Pharm Sci; 1998 Mar; 87(3):269-75. PubMed ID: 9523977
[TBL] [Abstract][Full Text] [Related]
30. Rupture and drug release characteristics of multi-reservoir type microspheres with poly(dl-lactide-co-glycolide) and poly(dl-lactide).
Matsumoto A; Matsukawa Y; Horikiri Y; Suzuki T
Int J Pharm; 2006 Dec; 327(1-2):110-6. PubMed ID: 16971073
[TBL] [Abstract][Full Text] [Related]
31. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
32. Injectable microcapsules prepared with biodegradable poly(alpha-hydroxy) acids for prolonged release of drugs.
Ogawa Y
J Biomater Sci Polym Ed; 1997; 8(5):391-409. PubMed ID: 9105978
[TBL] [Abstract][Full Text] [Related]
33. Towards developing surface eroding poly(alpha-hydroxy acids).
Xu XJ; Sy JC; Prasad Shastri V
Biomaterials; 2006 May; 27(15):3021-30. PubMed ID: 16455136
[TBL] [Abstract][Full Text] [Related]
34. Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems.
Luan X; Bodmeier R
J Control Release; 2006 Jan; 110(2):266-272. PubMed ID: 16300851
[TBL] [Abstract][Full Text] [Related]
35. Microencapsulation using poly(DL-lactic acid). III: Effect of polymer molecular weight on the release kinetics.
Jalil R; Nixon JR
J Microencapsul; 1990; 7(3):357-74. PubMed ID: 2384838
[TBL] [Abstract][Full Text] [Related]
36. Biodegradable microcapsules prepared by a w/o/w technique: effects of shear force to make a primary w/o emulsion on their morphology and protein release.
Sah HK; Toddywala R; Chien YW
J Microencapsul; 1995; 12(1):59-69. PubMed ID: 7730957
[TBL] [Abstract][Full Text] [Related]
37. Utilization of poly(DL-lactide-co-glycolide) nanoparticles for preparation of mini-depot tablets by direct compression.
Murakami H; Kobayashi M; Takeuchi H; Kawashima Y
J Control Release; 2000 Jun; 67(1):29-36. PubMed ID: 10773326
[TBL] [Abstract][Full Text] [Related]
38. Microencapsulation using poly (L-lactic acid) III: Effect of polymer molecular weight on the microcapsule properties.
Jalil R; Nixon JR
J Microencapsul; 1990; 7(1):41-52. PubMed ID: 2308053
[TBL] [Abstract][Full Text] [Related]
39. Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications.
Ma G
J Control Release; 2014 Nov; 193():324-40. PubMed ID: 25218676
[TBL] [Abstract][Full Text] [Related]
40. A method for the preparation of polylactic acid microcapsules of controlled particle size and drug loading.
Leelarasamee N; Howard SA; Malanga CJ; Ma JK
J Microencapsul; 1988; 5(2):147-57. PubMed ID: 3199303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
